{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:34:58Z","timestamp":1793061298126,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":325,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jchf.2025.102731","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T20:23:02Z","timestamp":1764620582000},"page":"102731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of Ischemic Heart Disease in Patients With Heart Failure"],"prefix":"10.1016","volume":"13","author":[{"given":"Lisa M.","family":"Mielniczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-8146","authenticated-orcid":false,"given":"Josip Andelo","family":"Borovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemar","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-5007","authenticated-orcid":false,"given":"Nadia","family":"Fida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-5981","authenticated-orcid":false,"given":"Judith S.","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Al Lamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-7070","authenticated-orcid":false,"given":"Nikhil","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divaka","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-3628","authenticated-orcid":false,"given":"Navin","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-3731","authenticated-orcid":false,"given":"Nosheen","family":"Reza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tamis-Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102731_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib2","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102731_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jchf.2024.04.025","article-title":"Where are we with treatment and prevention of heart failure in patients post-myocardial infarction?","volume":"12","author":"Carberry","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib4","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/eurheartj\/ehn503","article-title":"Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure","volume":"30","author":"Abrahamsson","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib6","first-page":"214","article-title":"In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure","volume":"5","author":"Zhang","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jchf.2025.102731_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/eurjhf\/hfs041","article-title":"Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007","volume":"14","author":"Ranasinghe","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/ejhf.2965","article-title":"Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016","volume":"25","author":"Docherty","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCHEARTFAILURE.111.964791","article-title":"Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure","volume":"5","author":"Chun","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacep.2021.06.020","article-title":"Arrhythmic and mortality outcomes among ischemic versus nonischemic cardiomyopathy patients receiving primary ICD therapy","volume":"8","author":"Narins","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jchf.2025.102731_bib11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jchf.2023.07.013","article-title":"Impact of coronary artery disease in women with newly diagnosed heart failure and reduced ejection fraction","volume":"11","author":"Nielsen","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"17","key":"10.1016\/j.jchf.2025.102731_bib12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jchf.2013.02.007","article-title":"Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes","volume":"1","author":"Bahit","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1388-9842(03)00159-4","article-title":"Congestive heart failure with preserved left ventricular systolic function after acute myocardial infarction: clinical and prognostic implications","volume":"5","author":"Moller","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib15","first-page":"710","article-title":"Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease. Article in Chinese","volume":"45","author":"Chai","year":"2017","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.jchf.2025.102731_bib16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jchf.2024.12.007","article-title":"Association of extracoronary calcification and incident heart failure in the Multiethnic Study of Atherosclerosis (MESA)","volume":"13","author":"Brar","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0002-9149(00)01107-3","article-title":"Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function","volume":"86","author":"O'Connor","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ejhf.142","article-title":"Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction","volume":"16","author":"Rusinaru","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib19","article-title":"ANOCA\/INOCA\/MINOCA: open artery ischemia","volume":"26","author":"Pepine","year":"2023","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.jchf.2025.102731_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007880","article-title":"Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA Global Collaboration","volume":"14","author":"Pasupathy","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2025.102731_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-022-00909-8","article-title":"Coronary blood flow in heart failure: cause, consequence and bystander","volume":"117","author":"Heusch","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102731_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jchf.2019.02.014","article-title":"Importance of nonobstructive coronary artery disease in the prognosis of patients with heart failure","volume":"7","author":"Braga","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/eurheartj\/ehab729","article-title":"Myocardial viability testing: all STICHed up, or about to be REVIVED?","volume":"43","author":"Ryan","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib26","article-title":"JACC: Advances Expert Panel Perspective: shared decision-making in multidisciplinary team-based cardiovascular care","volume":"3","author":"Perpetua","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jchf.2025.102731_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jchf.2022.07.011","article-title":"Trends in ischemic evaluation in new-onset heart failure without known coronary artery disease","volume":"10","author":"Andersson","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2016.05.060","article-title":"Underutilization of coronary artery disease testing among patients hospitalized with new-onset heart failure","volume":"68","author":"Doshi","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib29","article-title":"Testing for coronary artery disease in older patients with new-onset heart failure: findings from get with the guidelines-heart failure","volume":"13","author":"O'Connor","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib30","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib32","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0735-1097(99)00126-6","volume":"33","author":"Scanlon","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib33","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS. 2017\/JHFS. 2017 guideline on diagnosis and treatment of acute and chronic heart failure\u2013digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2025.102731_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11886-020-01304-2","article-title":"Ischemia and viability testing in new-onset heart failure","volume":"22","author":"Kassab","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jchf.2025.102731_bib35","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jacc.2021.07.004","article-title":"Myocardial viability assessment before surgical revascularization in ischemic cardiomyopathy: JACC Review Topic of the Week","volume":"78","author":"Panza","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12350-015-0096-5","article-title":"Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure","volume":"22","author":"Bax","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/HCI.0000000000000053","article-title":"State of the art: imaging for myocardial viability: a scientific statement from the American Heart Association","volume":"13","author":"Garcia","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2025.102731_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cpcardiol.2007.04.001","article-title":"Hibernating myocardium: diagnosis and patient outcomes","volume":"32","author":"Schinkel","year":"2007","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib39","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib41","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102731_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/eurheartj\/ehae844","article-title":"Prognostic impact of inducible ischaemia in ischaemic left ventricular dysfunction: the REVIVED-BCIS2 trial","volume":"46","author":"Morgan","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015502","article-title":"Stunned and hibernating myocardium: where are we nearly 4 decades later?","volume":"9","author":"Kloner","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102731_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.107.702993","article-title":"Stunning, hibernation, and assessment of myocardial viability","volume":"117","author":"Camici","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102731_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jcmg.2012.02.009","article-title":"CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials","volume":"5","author":"Romero","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2025.102731_bib47","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib48","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0735-1097(00)01087-1","article-title":"No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium","volume":"37","author":"Siebelink","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcmg.2009.02.017","article-title":"Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial","volume":"2","author":"D'Egidio","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2025.102731_bib51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib52","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib53","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2025.102731_bib54","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib55","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib56","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction","volume":"390","author":"Butler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCHEARTFAILURE.114.001155","article-title":"Aspirin for heart failure: theory- or evidence-based?","volume":"7","author":"Cleland","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11883-019-0800-z","article-title":"Statins in the prevention and treatment of heart failure: a review of the evidence","volume":"21","author":"Lee","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jchf.2025.102731_bib60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jchf.2013.12.007","article-title":"Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)","volume":"2","author":"Rogers","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib61","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.102731_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.jchf.2025.102731_bib63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib64","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC Review Topic of the Week","volume":"82","author":"Nelson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s44161-024-00600-2","article-title":"Implications and limitations of the CLEAR-SYNERGY trial for the use of low-dose colchicine in cardiovascular disease","volume":"4","author":"Misra","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jchf.2025.102731_bib66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/FJC.0000000000001672","article-title":"Colchicine in coronary artery disease: where do we stand?","volume":"85","author":"Bonaventura","year":"2025","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.jchf.2025.102731_bib67","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib68","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM198506273122603","article-title":"A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction","volume":"312","author":"Passamani","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib69","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib70","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacc.2024.04.043","article-title":"Impact of anatomical and viability-guided completeness of revascularization on clinical outcomes in ischemic cardiomyopathy","volume":"84","author":"Ezad","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamacardio.2022.3926","article-title":"Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review","volume":"8","author":"Stone","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib73","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/eurheartj\/ehaf080","article-title":"Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis","volume":"46","author":"Ryan","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib74","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamacardio.2020.0239","article-title":"Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting","volume":"5","author":"Sun","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib75","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/eurheartj\/ehab273","article-title":"Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"42","author":"Volz","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012527","article-title":"STICH3C: rationale and study protocol","volume":"16","author":"Fremes","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jchf.2025.102731_bib77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.xjon.2021.10.001","article-title":"High-risk cardiac surgery: time to explore a new paradigm","volume":"8","author":"Goldstein","year":"2021","journal-title":"JTCVS Open"},{"key":"10.1016\/j.jchf.2025.102731_bib78","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jchf.2024.03.010","article-title":"Effect of PCI on health status in ischemic left ventricular dysfunction: insights from REVIVED-BCIS2","volume":"12","author":"Ryan","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib79","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","article-title":"A placebo-controlled trial of percutaneous coronary intervention for stable angina","volume":"389","author":"Rajkumar","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib80","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib81","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2021.02.002","article-title":"Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program","volume":"235","author":"Brophy","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2025.102731_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib84","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib85","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jchf.2025.102731_bib86","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.athoracsur.2011.06.017","article-title":"Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over. 20 years","volume":"92","author":"Algarni","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jchf.2025.102731_bib87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jtcvs.2009.11.022","article-title":"Predictors of low cardiac output syndrome after isolated mitral valve surgery","volume":"140","author":"Maganti","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jchf.2025.102731_bib88","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/usc.2024.16","article-title":"Management of post-cardiotomy shock","volume":"18","author":"Hall","year":"2024","journal-title":"US Cardiol"},{"issue":"24","key":"10.1016\/j.jchf.2025.102731_bib89","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib91","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.healun.2023.07.012","article-title":"New system, old problem: increased wait time for high-priority transplant candidates","volume":"42","author":"Harris","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2025.102731_bib92","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.healun.2023.05.009","article-title":"Association of high-priority exceptions with waitlist mortality among heart transplant candidates","volume":"42","author":"Johnson","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2025.102731_bib93","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13063-020-04270-w","article-title":"Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)","volume":"21","author":"Rezende","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jchf.2025.102731_bib94","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102731_bib95","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.102731_bib98","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102731_bib100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cardfail.2024.10.006","article-title":"Assessment of revascularization preferences with best-worst scaling among patients with ischemic heart disease","volume":"31","author":"Mukhopadhyay","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102731_bib101","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.010923","article-title":"Developing an individualized patient decision aid for chronic coronary disease based on the ISCHEMIA trial: a mixed-methods study","volume":"17","author":"Nguyen","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2025.102731_bib102","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/CIRCULATIONAHA.121.058113","article-title":"What are adaptive platform clinical trials and what role may they have in cardiovascular medicine?","volume":"145","author":"Lawler","year":"2022","journal-title":"Circulation"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925006614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925006614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:21:07Z","timestamp":1793060467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925006614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213177925006614"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102731","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Ischemic Heart Disease in Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"102731"}}